If you purchased GSK ADRs during the Class Period you may be entitled to compensation without payment of any out of pocket ...
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.
Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...
GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results